Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02818283 · ClinicalTrials.gov registry record · NA
Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention
A NA study, sponsored by Ohio State University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02818283 is a NA study that was terminated before completion, run by Ohio State University. The registered enrollment target is 1 participants.
The verdict
NCT02818283, a NA study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Combination antiretroviral therapy (ART, HIV medications) dramatically increases the expected lifespan of HIV (Human Immunodeficiency Virus)infected patients; yet, the risks for cardiovascular disease (CVD), such as heart attacks and stroke, are increased in this population. This increased risk may be linked to persistent inflammation and activation of the immune system. Although the relationship between cardiovascular disease and HIV-infected individuals who are taking HIV medications is not well understood, the team of researchers involved in this study observed that a diet rich in soy, at levels recommended by the FDA (Federal Drug Administration), improved cholesterol levels and inflammation in individuals not infected with HIV. From this study, the researchers hope to gain understanding on how dietary soy will impact HIV-infected individuals who are taking HIV medications. Two pretzels with and without soy developed at OSU (Ohio State University) in the Department of Food Science and Technology and used in previous clinical trials will be used to investigate how the pretzel snacks will affect your cardiovascular disease risk, immunity, and how your body breaks down naturally occurring chemicals from soy.
Interventions
- DIETARY_SUPPLEMENT Soy Pretzel
- OTHER Wheat Pretzel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-06 |
| Est. Completion | 2023-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02818283
The ClinicalTrials.gov registry entry for NCT02818283 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Soy Pretzel is the first listed.
NCT02818283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02818283 about?
NCT02818283 is a clinical study titled "Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention". Combination antiretroviral therapy (ART, HIV medications) dramatically increases the expected lifespan of HIV (Human Immunodeficiency Virus)infected patients; yet, the risks for cardiovascular disease (CVD), such as heart attacks and stroke, are increased in this population. This increased risk may ...
What is the current status of trial NCT02818283?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-06. Estimated completion is 2023-10.
What interventions are being tested in trial NCT02818283?
The interventions under investigation include: Soy Pretzel (DIETARY_SUPPLEMENT), Wheat Pretzel (OTHER).
Who is sponsoring clinical trial NCT02818283?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.